Physician profile
Woosup Park
NPI 1043292998
$5,503.66
in general payments reported to CMS, 2019-2025
34 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $649 · 2023: $1,539 · 2024: $1,548 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,603.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,699.17 | 2022-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $735.11 | 2023-2025 | Endurant Iis, In.Pact Admiral, Hawkone |
| Bolton Medical INC | $565.46 | 2022-2023 | Treo Abdominal Stent-Graft System |
| Abbott Laboratories | $292.74 | 2023-2024 | Jeti Peripheral Catheter, Jeti All In One Non-Sterile Kit, Omnilink Elite |
| Cvrx, INC. | $265.22 | 2022 | |
| Surmodics, INC. | $232.71 | 2024-2025 | Pounce Thrombectomy, Pounce LP Thrombectomy, Pounce Xl Thrombectomy |
| Cook Medical LLC | $226.19 | 2022-2024 | Zenith Spiral-Z |
| Boston Scientific Corporation | $173.43 | 2022-2025 | Spyglass Discover, Embold Fibered |
| Baxter Healthcare | $141.41 | 2025 | Tisseel, Floseal |
| Stryker Corporation | $140.70 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $124.46 | 2021 | |
| Cardiva Medical, INC. | $112.00 | 2024-2025 | Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $99.49 | 2021-2023 | Saber |
| Tactile Systems Technology INC | $63.38 | 2025 | Nimbl, Flexitouch Plus |
| Lemaitre Vascular, INC. | $60.64 | 2023-2025 | Artegraft Vascular Graft |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $59.50 | 2021 | |
| Angiodynamics, INC. | $45.77 | 2024 | Alphavac |
| Silk Road Medical, INC. | $44.97 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Atricure, INC. | $41.63 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Argon Medical Devices, INC. | $40.19 | 2023-2024 | Clot Management, Cleaner |
| Shockwave Medical, INC | $38.97 | 2025 | |
| Amgen INC. | $37.42 | 2024 | Repatha |
| Imperative Care, INC | $33.57 | 2025 | Prodigy Catheter |
| Smith+Nephew, INC. | $31.34 | 2024 | Collagenase Santyl |
| Kerecis Limited | $29.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Scpharmaceuticals INC. | $23.04 | 2023 | |
| Integra Lifesciences Corporation | $22.70 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Becton, Dickinson and Company | $21.76 | 2024 | Rotarexs 6 F X 135 Cm |
| Philips North America LLC | $19.76 | 2023 | |
| Merck Sharp & Dohme LLC | $17.41 | 2024 | Verquvo |
| Ethicon US, LLC | $17.30 | 2025 | Stratafix |
| Sirtex Medical INC | $17.14 | 2024 | Lava Les (Liquid Embolic System) |
| Janssen Pharmaceuticals, INC | $16.56 | 2022 | |
| Davol INC. | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Woosup Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.